Lancet Global Health
Apr 2016 Volume 4 Number 4 e215-e286
http://www.thelancet.com/journals/langlo/issue/current

.
Comment
A second affordable oral cholera vaccine: implications for the global vaccine stockpile
Sachin N Desai, Lorenzo Pezzoli, Stephen Martin, Alejandro Costa, Carmen Rodriguez, Dominique Legros, William Perea
Summary
On Dec 23, 2015, WHO prequalified a second affordable oral cholera vaccine (OCV), Euvichol (Eubiologics, South Korea), which is expected to double current global OCV production and has the potential to further increase production capacity.1 The increased production will have implications for vaccine availability and reduced costs per dose, and will ultimately represent an added value for global cholera prevention and control.

.

Articles
Accuracy of the WHO Haemoglobin Colour Scale for the diagnosis of anaemia in primary health care settings in low-income countries: a systematic review and meta-analysis
Heiko Marn, Julia Alison Critchley

Timing of initiation, patterns of breastfeeding, and infant survival: prospective analysis of pooled data from three randomised trials
NEOVITA Study Group

The UN Commission on Life Saving Commodities 3 years on: global progress update and results of a multicountry assessment
Paul M Pronyk, Bennett Nemser, Blerta Maliqi, Nora Springstubb, Diana Sera, Rouslan Karimov, Elizabeth Katwan, Benedicte Walter, Pascal Bijleveld, UNCoLSC Technical Resource Teams, UN Agency Leads, UNCoLSC Monitoring and Evaluation Advisory Group